US Patent Issued to Charcot-Marie-Tooth Association, Trustees of the University of Pennsylvania on Sept. 1 for "Rat models for CMT2A that develop a progressive neuropathy" (Maryland, Missouri, Wisconsin, New York, Pennsylvania, California Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,327, issued on Sept. 1, was assigned to Charcot-Marie-Tooth Association (Glenolden, Pa.) and Trustees of the University of Pennsylvania (Philadelphia).

"Rat models for CMT2A that develop a progressive neuropathy" was invented by Mark Albert Scheideler (Silver Spring, Md.), Guojun Zhao (Saint Louis, Mo.), John Svaren (Madison, Wis.), David C. Chan (Pasadena, Calif.), Steven S. Scherer (Media, Pa.) and Taleen Hanania (Valhalla, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the engineering an animal model, preferably mammalian models, more preferably a rat model representing Charcot-Marie-Tooth disease 2A (CMT2A) ...